About
Technology
Issues
FAQ
Links
Official Page
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.